8,975
Views
18
CrossRef citations to date
0
Altmetric
Research Paper

Functional effects of human milk oligosaccharides (HMOs)

, , & ORCID Icon
Article: 2186115 | Received 30 Sep 2022, Accepted 22 Feb 2023, Published online: 17 Mar 2023

References

  • WHO. Infant and Young Child Feeding. (2021. Available online at: https://www.who.int/news-room/fact-sheets/detail/infant-and-young-child-feeding.
  • Meek JY, Noble L. Policy statement: breastfeeding and the use of human milk. Pediatrics. 2022 Jul 1;150(1):e2022057988. doi:10.1542/peds.2022-057988.
  • Agostoni C, Braegger C, Decsi T, Kolacek S, Koletzko B, Michaelsen KF, Mihatsch W, Moreno LA, Puntis J, Shamir R, et al. Breast-feeding: a commentary by the ESPGHAN committee on nutrition. J Pediatr Gastroenterol Nutr. 2009 Jul;49(1):112–33. doi:10.1097/MPG.0b013e31819f1e05.
  • Sprenger N, Tytgat HLP, Binia A, Austin S, Singhal A. Biology of human milk oligosaccharides: from basic science to clinical evidence. J Hum Nutr Diet. 2022 Apr; 35(2): 280–299. 10.1111/jhn.12990
  • Moubareck CA. Human milk microbiota and oligosaccharides: a glimpse into benefits, diversity, and correlations. Nutrients. 2021 Mar 29;13(4):1123.
  • Hill DR, Chow JM, Buck RH. Multifunctional benefits of prevalent HMOs: implications for infant health. Nutrients. 2021 Sep 25;13(10):3364. doi:10.3390/nu13103364.
  • Sankar MJ, Sinha B, Chowdhury R, Bhandari N, Taneja S, Martines J, Bahl R. Optimal breastfeeding practices and infant and child mortality: a systematic review and meta-analysis. Acta Paediatr. 2015 Dec; 104(467): 3–13. 10.1111/apa.13147
  • Christensen N, Bruun S, Søndergaard J, Christesen HT, Fisker N, Zachariassen G, Sangild PT, Husby S. Breastfeeding and infections in early childhood: a cohort study. Pediatrics. 2020 Nov; 146(5): e20191892. 10.1542/peds.2019-1892
  • Horta BL, Loret de Mola C, Victora CG. Long-term consequences of breastfeeding on cholesterol, obesity, systolic blood pressure and type 2 diabetes: a systematic review and meta-analysis. Acta Paediatr. 2015 Dec; 104(467): 30–37. 10.1111/apa.13133
  • Tschiderer L, Seekircher L, Kunutsor SK, Peters SAE, O’keeffe LM, Willeit P. Breastfeeding is associated with a reduced maternal cardiovascular risk: systematic review and meta-analysis involving data from 8 studies and 1 192 700 parous women. J Am Heart Assoc. 2022 Jan 18;11(2):e022746. doi:10.1161/JAHA.121.022746.
  • Stordal B. Breastfeeding reduces the risk of breast cancer: a call for action in high-income countries with low rates of breastfeeding. Cancer Med. 2022 Sep 26;12(4):4616–4625. doi:10.1002/cam4.5288.
  • Schraw JM, Bailey HD, Bonaventure A, Mora AM, Roman E, Mueller BA, Clavel J, Petridou ET, Karalexi M, Ntzani E, et al. Infant feeding practices and childhood acute leukemia: findings from the childhood cancer & leukemia international consortium. Int J Cancer. 2022 Oct 1;151(7):1013–1023. doi:10.1002/ijc.34062.
  • Matsumoto N, Yorifuji T, Nakamura K, Ikeda M, Tsukahara H, Doi H. Breastfeeding and risk of food allergy: a nationwide birth cohort in Japan. Allergol Int. 2020 Jan;69(1):91–97.
  • Bode L. The functional biology of human milk oligosaccharides. Early Hum Dev. 2015 Nov;91(11):619–622.
  • Bode L. Human milk oligosaccharides: every baby needs a sugar mama. Glycobiology. 2012 Sep;22(9):1147–1162.
  • Kunz C. Historical aspects of human milk oligosaccharides. Adv Nutr. 2012 May 1;3(3):430S–439S.
  • Kuhn R. Les oligosaccharides du lait [Oligosaccharides of milk]. Bull Soc Chim Biol (Paris). 1958;40:297–314.
  • Grimmonprez L, Montreuil J. Etude des fractions glycanniques des glycosphingolipides totaux de la membrane des globules lipidiques du lait de femme [The glycan fraction of the total glycosphingolipids of the human milk fat globule membrane]. Biochimie. 1977;59:899–907.
  • Kunz C, Rudloff S, Baier W, Klein N, Strobel S. Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annu Rev Nutr. 2000;20:699–722.
  • Zhang B, Li LQ, Liu F, Wu JY. Human milk oligosaccharides and infant gut microbiota: molecular structures, utilization strategies and immune function. Carbohydr Polym. 2022 Jan 15;276:118738.
  • Urashima T, Asakuma S, Leo F, Fukuda K, Messer M, Oftedal OT. The predominance of type I oligosaccharides is a feature specific to human breast milk. Adv Nutr. 2012 May 1;3(3):473S–482S.
  • Wiciński M, Sawicka E, Gębalski J, Kubiak K, Malinowski B. Human milk oligosaccharides: health benefits, potential applications in infant formulas, and pharmacology. Nutrients. 2020 Jan 20;12(1):266.
  • Hahn WH, Kim J, Song S, Park S, Kang NM. The human milk oligosaccharides are not affected by pasteurization and freeze-drying. J Matern Fetal Neonatal Med. 2019 Mar;32(6):985–991.
  • Smilowitz JT, Lebrilla CB, Mills DA, German JB, Freeman SL. Breast milk oligosaccharides: structure-function relationships in the neonate. Annu Rev Nutr. 2014;34:143–169.
  • Bosheva M, Tokodi I, Krasnow A, Pedersen HK, Lukjancenko O, Eklund AC, Grathwohl D, Sprenger N, Berger B, Cercamondi CI. HMO study investigator consortium. infant formula with a specific blend of five human milk oligosaccharides drives the gut microbiota development and improves gut maturation markers: a randomized controlled trial. Front Nutr. 2022 Jul 6;9:920362.
  • Fabiano V, Indrio F, Verduci E, Calcaterra V, Pop TL, Mari A, Zuccotti GV, Cullu Cokugras F, Pettoello-Mantovani M, Goulet O. Term infant formulas influencing gut microbiota: an overview. Nutrients. 2021 Nov 23;13(12):4200.
  • Conze DB, Kruger CL, Symonds JM, Lodder R, Schönknecht YB, Ho M, Derya SM, Parkot J, Parschat K. Weighted analysis of 2’-fucosyllactose, 3-fucosyllactose, lacto-N-tetraose, 3’-sialyllactose, and 6’-sialyllactose concentrations in human milk. Food Chem Toxicol. 2022 May;163:112877.
  • Cheema AS, Gridneva Z, Furst AJ, Roman AS, Trevenen ML, Turlach BA, Lai CT, Stinson LF, Bode L, Payne MS, et al. Human milk oligosaccharides and bacterial profile modulate infant body composition during exclusive breastfeeding. Int J Mol Sci. 2022 Mar 5;23(5):2865.
  • Zivkovic AM, Barile D. Bovine milk as a source of functional oligosaccharides for improving human health. Adv Nutr. 2011 May;2(3):284–289.
  • Thum C, Wall CR, Weiss GA, Wang W, Szeto IM, Day L. Changes in HMO concentrations throughout lactation: influencing factors, health effects and opportunities. Nutrients. 2021 Jun 30;13(7):2272.
  • Zhang S, Li T, Xie J, Zhang D, Pi C, Zhou L, Yang W. Gold standard for nutrition: a review of human milk oligosaccharide and its effects on infant gut microbiota. Microb Cell Fact. 2021 May 28;20(1):108.
  • Samuel TM, Binia A, de Castro CA, Thakkar SK, Billeaud C, Agosti M, Al-Jashi I, Costeira MJ, Marchini G, Martínez-Costa C, et al. Impact of maternal characteristics on human milk oligosaccharide composition over the first 4 months of lactation in a cohort of healthy European mothers. Sci Rep. 2019 Aug 13;9(1):11767.
  • Plows JF, Berger PK, Jones RB, Alderete TL, Yonemitsu C, Najera JA, Khwajazada S, Bode L, Goran MI. Longitudinal changes in human milk oligosaccharides (HMOs) over the course of 24 months of lactation. J Nutr. 2021 Apr 8;151(4):876–882.
  • Thurl S, Munzert M, Henker J, Boehm G, Müller-Werner B, Jelinek J, Stahl B. Variation of human milk oligosaccharides in relation to milk groups and lactational periods. Br J Nutr. 2010 Nov;104(9):1261–1271.
  • Liu S, Cai X, Wang J, Mao Y, Zou Y, Tian F, Peng B, Hu J, Zhao Y, Wang S. Six oligosaccharides’ variation in breast milk: a study in south China from 0 to 400 days postpartum. Nutrients. 2021 Nov 11;13(11):4017.
  • Zhu Y, Wan L, Li W, Ni D, Zhang W, Yan X, Mu W. Recent advances on 2’-fucosyllactose: physiological properties, applications, and production approaches. Crit Rev Food Sci Nutr. 2022;62:2083–2092.
  • Azad MB, Robertson B, Atakora F, Becker AB, Subbarao P, Moraes TJ, Mandhane PJ, Turvey SE, Lefebvre DL, Sears MR, et al. Human milk oligosaccharide concentrations are associated with multiple fixed and modifiable maternal characteristics, environmental factors, and feeding practices. J Nutr. 2018 Nov 1;148(11):1733–1742.
  • Seppo AE, Autran CA, Bode L, Järvinen KM. Human milk oligosaccharides and development of cow’s milk allergy in infants. J Allergy Clin Immunol. 2017 Feb;139(2):708–711.e5.
  • Sprenger N, Odenwald H, Kukkonen AK, Kuitunen M, Savilahti E, Kunz C. FUT2-dependent breast milk oligosaccharides and allergy at 2 and 5 years of age in infants with high hereditary allergy risk. Eur J Nutr. 2017 Apr;56(3):1293–1301.
  • Thurl S, Munzert M, Boehm G, Matthews C, Stahl B. Systematic review of the concentrations of oligosaccharides in human milk. Nutr Rev. 2017 Nov 1;75(11):920–933.
  • Ackerman DL, Craft KM, Doster RS, Weitkamp JH, Aronoff DM, Gaddy JA, Townsend SD. Antimicrobial and antibiofilm activity of human milk Oligosaccharides against Streptococcus agalactiae, Staphylococcus aureus, and Acinetobacter baumannii. ACS Infect Dis. 2018 Mar 9;4(3):315–324.
  • Kunz C, Meyer C, Collado MC, Geiger L, García-Mantrana I, Bertua-Ríos B, Martínez-Costa C, Borsch C, Rudloff S. Influence of gestational age, secretor, and lewis blood group status on the oligosaccharide content of human milk. J Pediatr Gastroenterol Nutr. 2017 May;64(5):789–798.
  • McGuire MK, Meehan CL, McGuire MA, Williams JE, Foster J, Sellen DW, Kamau-Mbuthia EW, Kamundia EW, Mbugua S, et al. What’s normal? Oligosaccharide concentrations and profiles in milk produced by healthy women vary geographically. Am J Clin Nutr. 2017 May;105(5):1086–1100.
  • Totten SM, Zivkovic AM, Wu S, Ngyuen U, Freeman SL, Ruhaak LR, Darboe MK, German JB, Prentice AM, Lebrilla CB. Comprehensive profiles of human milk oligosaccharides yield highly sensitive and specific markers for determining secretor status in lactating mothers. J Proteome Res. 2012 Dec 7;11(12):6124–6133.
  • Davis JC, Lewis ZT, Krishnan S, Bernstein RM, Moore SE, Prentice AM, Mills DA, Lebrilla CB, Zivkovic AM. Growth and morbidity of Gambian infants are influenced by maternal milk Oligosaccharides and Infant Gut Microbiota. Sci Rep. 2017 Jan 12;7:40466.
  • Gabrielli O, Zampini L, Galeazzi T, Padella L, Santoro L, Peila C, Giuliani F, Bertino E, Fabris C, Coppa GV. Preterm milk oligosaccharides during the first month of lactation. Pediatrics. 2011 Dec;128(6):e1520–31.
  • Sundekilde UK, Downey E, O’mahony JA, O’shea CA, Ryan CA, Kelly AL, Bertram HC. The effect of gestational and lactational age on the human milk Metabolome. Nutrients. 2016 May 19;8(5):304.
  • Corona L, Lussu A, Bosco A, Pintus R, Cesare Marincola F, Fanos V, Dessì A. Human milk oligosaccharides: a comprehensive review towards Metabolomics. Children (Basel). 2021 Sep 14;8(9):804.
  • Saben JL, Sims CR, Abraham A, Bode L, Andres A. Human milk oligosaccharide concentrations and infant intakes are associated with maternal overweight and obesity and predict infant growth. Nutrients. 2021 Jan 29;13(2):446.
  • Wang S, Wei Y, Liu L, Li Z. Association between breastmilk microbiota and food allergy in infants. Front Cell Infect Microbiol. 2022 Jan 12;11:770913.
  • Lagström H, Rautava S, Ollila H, Kaljonen A, Turta O, Mäkelä J, Yonemitsu C, Gupta J, Bode L. Associations between human milk oligosaccharides and growth in infancy and early childhood. Am J Clin Nutr. 2020 Apr 1;111(4):769–778.
  • Selma-Royo M, Calvo Lerma J, Cortés-Macías E, Collado MC. Human milk microbiome: from actual knowledge to future perspective. Semin Perinatol. 2021 Oct;45(6):151450.
  • Neville J, Pawlak R, Chang M, Furst A, Bode L, Perrin MT. A cross-sectional assessment of human milk oligosaccharide composition of vegan, vegetarian, and nonvegetarian mothers. Breastfeed Med. 2022 Mar;17(3):210–217.
  • Plows JF, Berger PK, Jones RB, Yonemitsu C, Ryoo JH, Alderete TL, Bode L, Goran MI. Associations between human milk oligosaccharides (HMOs) and eating behaviour in Hispanic infants at 1 and 6 months of age. Pediatr Obes. 2020 Dec;15(12):e12686.
  • Binia A, Lavalle L, Chen C, Austin S, Agosti M, Al-Jashi I, Pereira AB, Costeira MJ, Silva MG, Marchini G, et al. Human milk oligosaccharides, infant growth, and adiposity over the first 4 months of lactation. Pediatr Res. 2021 Sep;90(3):684–693.
  • Menzel P, Vogel M, Austin S, Sprenger N, Grafe N, Hilbert C, Jurkutat A, Kiess W, Binia A. Concentrations of oligosaccharides in human milk and child growth. BMC Pediatr. 2021 Oct 30;21(1):481.
  • Gridneva Z, Rea A, Tie WJ, Lai CT, Kugananthan S, Ward LC, Murray K, Hartmann PE, Geddes DT. Carbohydrates in human milk and body composition of term infants during the first 12 months of Lactation. Nutrients. 2019 Jun 28;11(7):1472.
  • Alderete TL, Autran C, Brekke BE, Knight R, Bode L, Goran MI, Fields DA. Associations between human milk oligosaccharides and infant body composition in the first 6 mo of life. Am J Clin Nutr. 2015 Dec;102(6):1381–1388.
  • Charbonneau MR, O’donnell D, Blanton LV, Totten SM, Davis JC, Barratt MJ, Cheng J, Guruge J, Talcott M, Bain JR, et al. Sialylated milk oligosaccharides promote microbiota-dependent growth in models of infant undernutrition. Cell. 2016 Feb 25;164(5):859–871.
  • Spevacek AR, Smilowitz JT, Chin EL, Underwood MA, German JB, Slupsky CM. Infant maturity at birth reveals minor differences in the maternal milk metabolome in the first month of lactation. J Nutr. 2015 Aug;145(8):1698–1708.
  • Nuzhat S, Palit P, Mahfuz M, Islam MR, Hasan SMT, Islam MM, Sarker SA, Kyle DJ, Flannery RL, Vinjamuri A, et al. Association of human milk oligosaccharides and nutritional status of young infants among Bangladeshi mother-infant dyads. Sci Rep. 2022 Jun 8;12(1):9456.
  • Robertson RC, Manges AR, Finlay BB, Prendergast AJ. The human microbiome and child growth - first 1000 days and beyond. Trends Microbiol. 2019 Feb;27(2):131–147.
  • Laursen MF. Gut Microbiota development: influence of diet from infancy to toddlerhood. Ann Nutr Metab. 2021 Aug;30:1–14.
  • Chu DM, Ma J, Prince AL, Antony KM, Seferovic MD, Aagaard KM. Maturation of the infant microbiome community structure and function across multiple body sites and in relation to mode of delivery. Nat Med. 2017 Mar;23(3):314–326.
  • Stewart CJ, Ajami NJ, O’brien JL, Hutchinson DS, Smith DP, Wong MC, Ross MC, Lloyd RE, Doddapaneni H, Metcalf GA, et al. Temporal development of the gut microbiome in early childhood from the TEDDY study. Nature. 2018 Oct;562(7728):583–588.
  • Martin FP, Tytgat HLP, Krogh Pedersen H, Moine D, Eklund AC, Berger B, Sprenger N. Host-microbial co-metabolites modulated by human milk oligosaccharides relate to reduced risk of respiratory tract infections. Front Nutr. 2022 Aug 4;9:935711.
  • Hao H, Zhu L, Faden HS. The milk-based diet of infancy and the gut microbiome. Gastroenterol Rep (Oxf). 2019 Aug;7(4):246–249.
  • Lin C, Lin Y, Zhang H, Wang G, Zhao J, Zhang H, Chen W. Intestinal ‘infant-type’ bifidobacteria mediate immune system development in the first 1000 days of life. Nutrients. 2022 Apr 2;14(7):1498.
  • Ojima MN, Jiang L, Arzamasov AA, Yoshida K, Odamaki T, Xiao J, Nakajima A, Kitaoka M, Hirose J, Urashima T, et al. Priority effects shape the structure of infant-type Bifidobacterium communities on human milk oligosaccharides. Isme J. 2022 Sep;16(9):2265–2279.
  • Masi AC, Stewart CJ. Untangling human milk oligosaccharides and infant gut microbiome. iScience. 2021 Dec 1;25(1):103542.
  • Cabrera-Rubio R, Kunz C, Rudloff S, García-Mantrana I, Crehuá-Gaudiza E, Martínez-Costa C, Collado MC. Association of maternal secretor status and human milk oligosaccharides with milk microbiota: an observational pilot study. J Pediatr Gastroenterol Nutr. 2019 Feb;68(2):256–263.
  • Matsuki T, Yahagi K, Mori H, Matsumoto H, Hara T, Tajima S, Ogawa E, Kodama H, Yamamoto K, Yamada T, et al. A key genetic factor for fucosyllactose utilization affects infant gut microbiota development. Nat Commun. 2016 Jun 24;7:11939.
  • Lewis ZT, Totten SM, Smilowitz JT, Popovic M, Parker E, Lemay DG, Van Tassell ML, Miller MJ, Jin YS, German JB, et al. Maternal fucosyltransferase 2 status affects the gut bifidobacterial communities of breastfed infants. Microbiome. 2015 Apr 10;3:13.
  • Morrow AL, Ruiz-Palacios GM, Jiang X, Newburg DS. Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. J Nutr. 2005 May;135(5):1304–1307.
  • Yu ZT, Chen C, Newburg DS. Utilization of major fucosylated and sialylated human milk oligosaccharides by isolated human gut microbes. Glycobiology. 2013 Nov;23(11):1281–1292.
  • Bridgman SL, Azad MB, Field CJ, Haqq AM, Becker AB, Mandhane PJ, Subbarao P, Turvey SE, Sears MR, Scott JA, et al. Fecal short-chain fatty acid variations by breastfeeding status in infants at 4 months: differences in relative versus absolute concentrations. Front Nutr. 2017 Apr 10;4:11.
  • D’souza G, Shitut S, Preussger D, Yousif G, Waschina S, Kost C. Ecology and evolution of metabolic cross-feeding interactions in bacteria. Nat Prod Rep. 2018 May 1;35(5):455–488.
  • Bode L, Jantscher-Krenn E. Structure-function relationships of human milk oligosaccharides. Adv Nutr. 2012 May 1;3(3):383S–391S.
  • Schwab C, Ruscheweyh HJ, Bunesova V, Pham VT, Beerenwinkel N, Lacroix C. Trophic interactions of infant Bifidobacteria and Eubacterium hallii during L-Fucose and Fucosyllactose degradation. Front Microbiol. 2017 Jan 30;8:95.
  • Dogra SK, Martin FP, Donnicola D, Julita M, Berger B, Sprenger N. Human milk Oligosaccharide-stimulated Bifidobacterium species contribute to prevent later respiratory tract infections. Microorganisms. 2021 Sep 12;9(9):1939.
  • Cheng L, Kong C, Walvoort MTC, Faas MM, de Vos P. Human milk Oligosaccharides differently modulate goblet cells under homeostatic, proinflammatory conditions and ER stress. Mol Nutr Food Res. 2020 Mar;64(5):e1900976.
  • Natividad JM, Marsaux B, Rodenas CLG, Rytz A, Vandevijver G, Marzorati M, Van den Abbeele P, Calatayud M, Rochat F. Human milk Oligosaccharides and Lactose differentially affect infant Gut Microbiota and Intestinal barrier in vitro. Nutrients. 2022 Jun 19;14(12):2546.
  • Kong C, Elderman M, Cheng L, de Haan Bj, Nauta A, de Vos P. Modulation of intestinal Epithelial Glycocalyx development by human milk Oligosaccharides and non-digestible carbohydrates. Mol Nutr Food Res. 2019 Sep;63(17):e1900303.
  • Williams JE, Price WJ, Shafii B, Yahvah KM, Bode L, McGuire MA, McGuire MK. Relationships among microbial communities, maternal cells, oligosaccharides, and macronutrients in human milk. J Hum Lact. 2017 Aug;33(3):540–551.
  • Aakko J, Kumar H, Rautava S, Wise A, Autran C, Bode L, Isolauri E, Salminen S. Human milk oligosaccharide categories define the microbiota composition in human colostrum. Benef Microbes. 2017 Aug 24;8(4):563–567.
  • Moossavi S, Atakora F, Miliku K, Sepehri S, Robertson B, Duan QL, Becker AB, Mandhane PJ, Turvey SE, Moraes TJ, et al. Integrated analysis of human milk microbiota with oligosaccharides and fatty acids in the CHILD cohort. Front Nutr. 2019 May 16;6:58.
  • Autran CA, Kellman BP, Kim JH, Asztalos E, Blood AB, Spence ECH, Patel AL, Hou J, Lewis NE, Bode L. Human milk oligosaccharide composition predicts risk of necrotising enterocolitis in preterm infants. Gut. 2018 Jun;67(6):1064–1070.
  • Patel AL, Kim JH. Human milk and necrotizing enterocolitis. Semin Pediatr Surg. 2018 Feb;27(1):34–38.
  • Wu RY, Li B, Koike Y, Määttänen P, Miyake H, Cadete M, Johnson-Henry KC, Botts SR, Lee C, Abrahamsson TR, et al. Human milk Oligosaccharides increase mucin expression in experimental Necrotizing Enterocolitis. Mol Nutr Food Res. 2019 Feb;63(3):e1800658.
  • Morrow AL, Meinzen-Derr J, Huang P, Schibler KR, Cahill T, Keddache M, Kallapur SG, Newburg DS, Tabangin M, Warner BB, et al. Fucosyltransferase 2 non-secretor and low secretor status predicts severe outcomes in premature infants. J Pediatr. 2011 May;158(5):745–751.
  • Masi AC, Embleton ND, Lamb CA, Young G, Granger CL, Najera J, Smith DP, Hoffman KL, Petrosino JF, Bode L, et al. Human milk oligosaccharide DSLNT and gut microbiome in preterm infants predicts necrotising enterocolitis. Gut. 2021 Dec;70(12):2273–2282.
  • Wejryd E, Martí M, Marchini G, Werme A, Jonsson B, Landberg E, Abrahamsson TR. Low diversity of human milk Oligosaccharides is Associated with Necrotising Enterocolitis in Extremely Low Birth Weight Infants. Nutrients. 2018 Oct 20;10(10):1556.
  • Nolan LS, Rimer JM, Good M. The role of human milk Oligosaccharides and Probiotics on the Neonatal Microbiome and risk of Necrotizing Enterocolitis: a narrative review. Nutrients. 2020 Oct 6;12(10):3052.
  • Jantscher-Krenn E, Lauwaet T, Bliss LA, Reed SL, Gillin FD, Bode L. Human milk oligosaccharides reduce Entamoeba histolytica attachment and cytotoxicity in vitro. Br J Nutr. 2012 Nov 28;108(10):1839–1846.
  • Sodhi CP, Wipf P, Yamaguchi Y, Fulton WB, Kovler M, Niño DF, Zhou Q, Banfield E, Werts AD, Ladd MR, et al. The human milk oligosaccharides 2’-fucosyllactose and 6’-sialyllactose protect against the development of necrotizing enterocolitis by inhibiting toll-like receptor 4 signaling. Pediatr Res. 2021 Jan;89(1):91–101.
  • Good M, Sodhi CP, Yamaguchi Y, Jia H, Lu P, Fulton WB, Martin LY, Prindle T, Nino DF, Zhou Q, et al. The human milk oligosaccharide 2’-fucosyllactose attenuates the severity of experimental necrotising enterocolitis by enhancing mesenteric perfusion in the neonatal intestine. Br J Nutr. 2016 Oct;116(7):1175–1187.
  • Morrow AL, Ruiz-Palacios GM, Altaye M, Jiang X, Guerrero ML, Meinzen-Derr JK, Farkas T, Chaturvedi P, Pickering LK, Newburg DS. Human milk oligosaccharides are associated with protection against diarrhea in breast-fed infants. J Pediatr. 2004 Sep;145(3):297–303.
  • Stepans MB, Wilhelm SL, Hertzog M, Rodehorst TK, Blaney S, Clemens B, Polak JJ, Newburg DS. Early consumption of human milk oligosaccharides is inversely related to subsequent risk of respiratory and enteric disease in infants. Breastfeed Med. 2006 Winter;1(4):207–215.
  • Hamer DH, Solomon H, Das G, Knabe T, Beard J, Simon J, Nisar YB, MacLeod WB. Importance of breastfeeding and complementary feeding for management and prevention of childhood diarrhoea in low- and middle-income countries. J Glob Health. 2022 Aug 3;12:10011.
  • Triantis V, Bode L, van Neerven RJJ. Immunological effects of human milk Oligosaccharides. Front Pediatr. 2018 Jul 2;6:190.
  • Barton SJ, Murray R, Lillycrop KA, Inskip HM, Harvey NC, Cooper C, Karnani N, Zolezzi IS, Sprenger N, Godfrey KM, et al. FUT2 genetic variants and reported respiratory and gastrointestinal illnesses during infancy. J Infect Dis. 2019 Feb 15;219(5):836–843.
  • Newburg DS, Ruiz-Palacios GM, Altaye M, Chaturvedi P, Guerrero ML, Meinzen-Derr JK, Morrow AL. Human milk alphal,2-linked fucosylated oligosaccharides decrease risk of diarrhea due to stable toxin of E. coli in breastfed infants. Adv Exp Med Biol. 2004;554:457–461.
  • Torres Roldan VD, Urtecho SM, Gupta J, Yonemitsu C, Cárcamo CP, Bode L, Ochoa TJ. Human milk oligosaccharides and their association with late-onset neonatal sepsis in Peruvian very-low-birth-weight infants. Am J Clin Nutr. 2020 Jul 1;112(1):106–112.
  • Ramani S, Stewart CJ, Laucirica DR, Ajami NJ, Robertson B, Autran CA, Shinge D, Rani S, Anandan S, Hu L, et al. Human milk oligosaccharides, milk microbiome and infant gut microbiome modulate neonatal rotavirus infection. Nat Commun. 2018 Nov 27;9(1):5010.
  • Ruvoën-Clouet N, Mas E, Marionneau S, Guillon P, Lombardo D, Le Pendu J. Bile-salt-stimulated lipase and mucins from milk of ‘secretor’ mothers inhibit the binding of Norwalk virus capsids to their carbohydrate ligands. Biochem J. 2006 Feb 1;393(Pt 3):627–634.
  • Hanisch FG, Hansman GS, Morozov V, Kunz C, Schroten H. Avidity of α-fucose on human milk oligosaccharides and blood group-unrelated oligo/polyfucoses is essential for potent norovirus-binding targets. J Biol Chem. 2018 Jul 27;293(30):11955–11965.
  • Siziba LP, Mank M, Stahl B, Kurz D, Gonsalves J, Blijenberg B, Rothenbacher D, Genuneit J. Associations of human milk Oligosaccharides with otitis media and lower and upper respiratory tract infections up to 2 years: the Ulm SPATZ health study. Front Nutr. 2021 Oct 25;8:761129.
  • Van Niekerk E, Autran CA, Nel DG, Kirsten GF, Blaauw R, Bode L. Human milk oligosaccharides differ between HIV-infected and HIV-uninfected mothers and are related to necrotizing enterocolitis incidence in their preterm very-low-birth-weight infants. J Nutr. 2014 Aug;144(8):1227–1233.
  • Bode L, Kuhn L, Kim HY, Hsiao L, Nissan C, Sinkala M, Kankasa C, Mwiya M, Thea DM, Aldrovandi GM. Human milk oligosaccharide concentration and risk of postnatal transmission of HIV through breastfeeding. Am J Clin Nutr. 2012 Oct;96(4):831–839.
  • Kuhn L, Kim HY, Hsiao L, Nissan C, Kankasa C, Mwiya M, Thea DM, Aldrovandi GM, Bode L. Oligosaccharide composition of breast milk influences survival of uninfected children born to HIV-infected mothers in Lusaka, Zambia. J Nutr. 2015 Jan;145(1):66–72.
  • Moore RE, Xu LL, Townsend SD. Prospecting human milk Oligosaccharides as a defense against viral infections. ACS Infect Dis. 2021 Feb 12;7(2):254–263.
  • Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K, Tobe T, Clarke JM, Topping DL, Suzuki T, et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature. 2011 Jan 27;469(7331):543–547.
  • Antunes KH, Fachi JL, de Paula R, da Silva EF, Pral LP, Dos Santos AÁ, Dias GBM, Vargas JE, Puga R, Mayer FQ, et al. Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response. Nat Commun. 2019 Jul 22;10(1):3273.
  • Yu Y, Mishra S, Song X, Lasanajak Y, Bradley KC, Tappert MM, Air GM, Steinhauer DA, Halder S, Cotmore S, et al. Functional glycomic analysis of human milk glycans reveals the presence of virus receptors and embryonic stem cell biomarkers. J Biol Chem. 2012 Dec 28;287(53):44784–44799.
  • Duska-McEwen G, Senft AP, Ruetschilling TL, Barrett EG, Buck RH. Human milk oligosaccharides enhance innate immunity to respiratory syncytial virus and influenza in vitro. Food Nutr Sci. 2014;5:1387–1398.
  • Lin AE, Autran CA, Szyszka A, Escajadillo T, Huang M, Godula K, Prudden AR, Boons GJ, Lewis AL, Doran KS, et al. Human milk oligosaccharides inhibit growth of group B Streptococcus. J Biol Chem. 2017 Jul 7;292(27):11243–11249.
  • Donovan SM, Comstock SS. Human milk Oligosaccharides influence Neonatal Mucosal and systemic immunity. Ann Nutr Metab. 2016;69:42–51.
  • Puccio G, Alliet P, Cajozzo C, Janssens E, Corsello G, Sprenger N, Wernimont S, Egli D, Gosoniu L, Steenhout P. Effects of infant formula with human milk Oligosaccharides on growth and morbidity: a randomized multicenter trial. J Pediatr Gastroenterol Nutr. 2017 Apr;64(4):624–631.
  • Singh RP, Niharika J, Kondepudi KK, Bishnoi M, Tingirikari JMR. Recent understanding of human milk oligosaccharides in establishing infant gut microbiome and roles in immune system. Food Res Int. 2022 Jan;151:110884.
  • Walsh C, Lane JA, van Sinderen D, Hickey RM. Human milk oligosaccharides: shaping the infant gut microbiota and supporting health. J Funct Foods. 2020 Sep;72:104074.
  • Johannes L, Jacob R, Leffler H. Galectins at a glance. J Cell Sci. 2018 May 1;131(9):jcs208884.
  • Xiao L, van De Worp WR, Stassen R, van Maastrigt C, Kettelarij N, Stahl B, Blijenberg B, Overbeek SA, Folkerts G, Garssen J, et al. Human milk oligosaccharides promote immune tolerance via direct interactions with human dendritic cells. Eur J Immunol. 2019 Jul;49(7):1001–1014.
  • Ayechu-Muruzabal V, Overbeek SA, Kostadinova AI, Stahl B, Garssen J, Van’t Land B, Willemsen LEM. Exposure of intestinal Epithelial cells to 2’-Fucosyllactose and CpG enhances Galectin release and instructs dendritic cells to drive Th1 and regulatory-type immune development. Biomolecules. 2020 May 19;10(5):784.
  • Kurakevich E, Hennet T, Hausmann M, Rogler G, Borsig L. Milk oligosaccharide sialyl(α2,3)lactose activates intestinal CD11c+ cells through TLR4. Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17444–17449.
  • Šuligoj T, Vigsnæs LK, Abbeele PVD, Apostolou A, Karalis K, Savva GM, McConnell B, Juge N. Effects of human milk oligosaccharides on the adult Gut Microbiota and barrier function. Nutrients. 2020 Sep 13;12(9):2808.
  • Xiao L, Van’t Land B, Engen PA, Naqib A, Green SJ, Nato A, Leusink-Muis T, Garssen J, Keshavarzian A, Stahl B, et al. Human milk oligosaccharides protect against the development of autoimmune diabetes in NOD-mice. Sci Rep. 2018 Mar 1;8(1):3829.
  • Xiao L, Leusink-Muis T, Kettelarij N, van Ark I, Blijenberg B, Hesen NA, Stahl B, Overbeek SA, Garssen J, Folkerts G, et al. Human milk Oligosaccharide 2’-Fucosyllactose improves innate and adaptive immunity in an influenza-specific murine vaccination model. Front Immunol. 2018 Mar 9;9:452.
  • Björkstén B, Naaber P, Sepp E, Mikelsaar M. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy. 1999 Mar;29(3):342–346.
  • Björkstén B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol. 2001 Oct;108(4):516–520.
  • Castillo-Courtade L, Han S, Lee S, Mian FM, Buck R, Forsythe P. Attenuation of food allergy symptoms following treatment with human milk oligosaccharides in a mouse model. Allergy. 2015 Sep;70(9):1091–1102.
  • Korpela K, Salonen A, Hickman B, Kunz C, Sprenger N, Kukkonen K, Savilahti E, Kuitunen M, de Vos WM. Fucosylated oligosaccharides in mother’s milk alleviate the effects of caesarean birth on infant gut microbiota. Sci Rep. 2018 Sep 13;8(1):13757.
  • Zimmermann P, Messina N, Mohn WW, Finlay BB, Curtis N. Association between the intestinal microbiota and allergic sensitization, eczema, and asthma: a systematic review. J Allergy Clin Immunol. 2019 Feb;143(2):467–485.
  • Siziba LP, Mank M, Stahl B, Kurz D, Gonsalves J, Blijenberg B, Rothenbacher D, Genuneit J. Human milk oligosaccharide profiles and child atopic dermatitis up to 2 years of age: the Ulm SPATZ health study. Pediatr Allergy Immunol. 2022 Feb;33(2):e13740.
  • Han SM, Binia A, Godfrey KM, El-Heis S, Cutfield WS. Do human milk oligosaccharides protect against infant atopic disorders and food allergy? Nutrients. 2020 Oct 21;12(10):3212.
  • Hobbs M, Jahan M, Ghorashi SA, Wang B. Current perspective of Sialylated milk Oligosaccharides in mammalian milk: implications for brain and gut health of newborns. Foods. 2021 Feb 21;10(2):473.
  • Hauser J, Pisa E, Arias Vásquez A, Tomasi F, Traversa A, Chiodi V, Martin FP, Sprenger N, Lukjancenko O, Zollinger A, et al. Sialylated human milk oligosaccharides program cognitive development through a non-genomic transmission mode. Mol Psychiatry. 2021 Jul;26(7):2854–2871.
  • Oliveros E, Vázquez E, Barranco A, Ramírez M, Gruart A, Delgado-García JM, Buck R, Rueda R, Martín MJ. Sialic acid and Sialylated Oligosaccharide supplementation during lactation improves learning and memory in rats. Nutrients. 2018 Oct 16;10(10):1519.
  • Tarr AJ, Galley JD, Fisher SE, Chichlowski M, Berg BM, Bailey MT. The prebiotics 3‘sialyllactose and 6‘sialyllactose diminish stressor-induced anxiety-like behavior and colonic microbiota alterations: evidence for effects on the gut-brain axis. Brain Behav Immun. 2015 Nov;50:166–177.
  • Cho S, Zhu Z, Li T, Baluyot K, Howell BR, Hazlett HC, Elison JT, Hauser J, Sprenger N, Wu D, et al. Human milk 3’-Sialyllactose is positively associated with language development during infancy. Am J Clin Nutr. 2021 Aug 2;114(2):588–597.
  • Oliveros E, Ramirez M, Vazquez E, Barranco A, Gruart A, Delgado-Garcia JM, Buck R, Rueda R, Martin MJ. Oral supplementation of 2’-fucosyllactose during lactation improves memory and learning in rats. J Nutr Biochem. 2016 May;31:20–27.
  • Murrey HE, Gama CI, Kalovidouris SA, Luo WI, Driggers EM, Porton B, Hsieh-Wilson LC. Protein fucosylation regulates synapsin Ia/Ib expression and neuronal morphology in primary hippocampal neurons. Proc Natl Acad Sci U S A. 2006 Jan 3;103(1):21–26.
  • Vázquez E, Barranco A, Ramírez M, Gruart A, Delgado-García JM, Martínez-Lara E, Blanco S, Martín MJ, Castanys E, Buck R, et al. Effects of a human milk oligosaccharide, 2’-fucosyllactose, on hippocampal long-term potentiation and learning capabilities in rodents. J Nutr Biochem. 2015 May;26(5):455–465.
  • Oliveros E, Martín MJ, Torres-Espínola FJ, Segura-Moreno MT, Ramírez M, Santos A, Buck R, Rueda R, Escudero M, Catena A, et al. Human milk levels of 2′-fucosyllactose and 6′-sialyllactose are positively associated with infant neurodevelopment and are not impacted by maternal BMI or diabetic status. J Nutr Food Sci. 2021;4:100024.
  • Berger PK, Plows JF, Jones RB, Alderete TL, Yonemitsu C, Poulsen M, Ryoo JH, Peterson BS, Bode L, Goran MI. Human milk oligosaccharide 2’-fucosyllactose links feedings at 1 month to cognitive development at 24 months in infants of normal and overweight mothers. PLoS One. 2020 Feb 12;15(2):e0228323.
  • Urashima T, Taufik E, Fukuda K, Asakuma S. Recent advances in studies on milk oligosaccharides of cows and other domestic farm animals. Biosci Biotechnol Biochem. 2013;77:455–466.
  • Hegar B, Wibowo Y, Basrowi RW, Ranuh RG, Sudarmo SM, Munasir Z, Atthiyah AF, Widodo AD, Supriatmo KM, Suryawan A, et al. The role of two human milk Oligosaccharides, 2’-Fucosyllactose and Lacto-N-Neotetraose, in infant nutrition. Pediatr Gastroenterol Hepatol Nutr. 2019 Jul;22(4):330–340.
  • Prieto PA. In vitro and clinical experiences with a human milk oligosaccharide, Lacto-N-neoTetraose, and Fructooligosaccharides. Foods Food Ingred J Jpn. 2005;210:1018–1030.
  • Marriage BJ, Buck RH, Goehring KC, Oliver JS, Williams JA. Infants fed a lower calorie formula with 2‘FL show growth and 2‘FL uptake like breast-fed infants. J Pediatr Gastroenterol Nutr. 2015 Dec;61(6):649–658.
  • Parschat K, Melsaether C, Jäpelt KR, Jennewein S. Clinical evaluation of 16-week supplementation with 5HMO-Mix in healthy-term human infants to determine tolerability, safety, and effect on growth. Nutrients. 2021 Aug 20;13(8):2871.
  • Vandenplas Y, de Halleux V, Arciszewska M, Lach P, Pokhylko V, Klymenko V, Schoen S, Abrahamse-Berkeveld M, Mulder KA, Porcel Rubio R, et al. A Partly fermented infant formula with postbiotics including 3’-GL, specific Oligosaccharides, 2’-FL, and milk fat supports adequate growth, is safe and well-tolerated in healthy term infants: a double-blind, randomised, controlled, multi-country trial. Nutrients. 2020 Nov 20;12(11):3560.
  • Lasekan J, Choe Y, Dvoretskiy S, Devitt A, Zhang S, Mackey A, Wulf K, Buck R, Steele C, Johnson M, et al. Growth and gastrointestinal tolerance in healthy term infants fed milk-based infant formula supplemented with five human milk Oligosaccharides (HMOs): a randomized multicenter trial. Nutrients. 2022 Jun 24;14(13):2625.
  • Ramirez-Farias C, Baggs GE, Marriage BJ. Growth, tolerance, and compliance of infants fed an extensively hydrolyzed infant formula with added 2’-FL Fucosyllactose (2’-FL) human milk Oligosaccharide. Nutrients. 2021 Jan 9;13(1):186.
  • Gold MS, Quinn PJ, Campbell DE, Peake J, Smart J, Robinson M, O’sullivan M, Vogt JK, Pedersen HK, Liu X, et al. Effects of an amino acid-based formula supplemented with two human milk oligosaccharides on growth, tolerability, safety, and gut microbiome in infants with cow’s milk protein allergy. Nutrients. 2022 May 30;14(11):2297.
  • Storm HM, Shepard J, Czerkies LM, Kineman B, Cohen SS, Reichert H, Carvalho R. 2’-Fucosyllactose is well tolerated in a 100% whey, partially hydrolyzed infant formula with Bifidobacterium lactis: a randomized controlled trial. Glob Pediatr Health. 2019 Mar 15;6:2333794X19833995.
  • Román E, Moreno Villares JM, Domínguez Ortega F, Carmona Martínez A, Picó Sirvent L, Santana Sandoval L, Casas Rivero J, Alshweki A, Cercamondi C, Dahbane S, et al. Real-world study in infants fed with an infant formula with two human milk oligosaccharides. Nutr Hosp. 2020 Aug 27;37(4):698–706.
  • Kajzer J, Oliver J, Marriage B. Gastrointestinal tolerance of formula supplemented with oligosaccharides. Faseb J. 2016;30:671–674.
  • Reverri EJ, Devitt AA, Kajzer JA, Baggs GE, Borschel MW. Review of the clinical experiences of feeding infants formula containing the human milk Oligosaccharide 2’-Fucosyllactose. Nutrients. 2018 Sep 21;10(10):1346.
  • Alliet P, Vandenplas Y, Roggero P, Jespers SNJ, Peeters S, Stalens JP, Kortman GAM, Amico M, Berger B, Sprenger N, et al. Safety and efficacy of a probiotic-containing infant formula supplemented with 2’-fucosyllactose: a double-blind randomized controlled trial. Nutr J. 2022 Feb 22;21(1):11.
  • Nogacka AM, Arboleya S, Nikpoor N, Auger J, Salazar N, Cuesta I, Alvarez-Buylla JR, Mantecón L, Solís G, Gueimonde M, et al. In Vitro probiotic modulation of the intestinal Microbiota and 2‘fucosyllactose consumption in fecal cultures from infants at two months of age. Microorganisms. 2022 Jan 29;10(2):318.
  • Berger B, Porta N, Foata F, Grathwohl D, Delley M, Moine D, Charpagne A, Siegwald L, Descombes P, Alliet P, et al. Linking human milk Oligosaccharides, infant fecal community types, and later risk to require antibiotics. mBio. 2020 Mar 17;11(2):e03196–19.
  • Vandenplas Y, Berger B, Carnielli VP, Ksiazyk J, Lagström H, Sanchez Luna M, Migacheva N, Mosselmans JM, Picaud JC, Possner M, et al. Human milk Oligosaccharides: 2’-Fucosyllactose (2’-FL) and Lacto-N-Neotetraose (LNnT) in infant formula. Nutrients. 2018 Aug 24;10(9):1161.
  • Marcobal A, Barboza M, Froehlich JW, Block DE, German JB, Lebrilla CB, Mills DA. Consumption of human milk oligosaccharides by gut-related microbes. J Agric Food Chem. 2010 May 12;58(9):5334–5340.
  • Estorninos E, Lawenko RB, Palestroque E, Sprenger N, Benyacoub J, Kortman GAM, Boekhorst J, Bettler J, Cercamondi CI, Berger B. Term infant formula supplemented with milk-derived oligosaccharides shifts the gut microbiota closer to that of human milk-fed infants and improves intestinal immune defense: a randomized controlled trial. Am J Clin Nutr. 2022 Jan 11;115(1):142–153.
  • Goehring KC, Marriage BJ, Oliver JS, Wilder JA, Barrett EG, Buck RH. Similar to those who are breastfed, infants fed a formula containing 2’-Fucosyllactose have lower inflammatory Cytokines in a randomized controlled trial. J Nutr. 2016 Dec;146(12):2559–2566.
  • Leung TF, Ulfman LH, Chong MKC, Hon KL, Imsl K, Chan PKS, Delsing DJ, Kortman GAM, Bovee-Oudenhoven IMJ. A randomized controlled trial of different young child formulas on upper respiratory and gastrointestinal tract infections in Chinese toddlers. Pediatr Allergy Immunol. 2020 Oct;31(7):745–754.
  • Koletzko S, Niggemann B, Arato A, Dias JA, Heuschkel R, Husby S, Mearin ML, Papadopoulou A, Ruemmele FM, Staiano A, et al. European society of pediatric Gastroenterology, Hepatology, and nutrition. diagnostic approach and management of cow’s-milk protein allergy in infants and children: eSPGHAN GI committee practical guidelines. J Pediatr Gastroenterol Nutr. 2012 Aug;55(2):221–229.
  • Nowak-Wegrzyn A, Czerkies L, Reyes K, Collins B, Heine RG. Confirmed Hypoallergenicity of a novel whey-based extensively hydrolyzed infant formula containing two human milk Oligosaccharides. Nutrients. 2019 Jun 26;11(7):1447.
  • Vandenplas Y, Żołnowska M, Berni Canani R, Ludman S, Tengelyi Z, Moreno-Álvarez A, Goh AEN, Gosoniu ML, Kirwan BA, Tadi M, et al. Effects of an extensively hydrolyzed formula supplemented with two human milk Oligosaccharides on growth, tolerability, safety and infection risk in infants with cow’s milk protein allergy: a randomized, multi-center trial. Nutrients. 2022 Jan 26;14(3):530.
  • Arslanoglu S, Moro GE, Boehm G. Early supplementation of prebiotic oligosaccharides protects formula-fed infants against infections during the first 6 months of life. J Nutr. 2007 Nov;137(11):2420–2424.
  • Arslanoglu S, Moro GE, Boehm G, Wienz F, Stahl B, Bertino E. Early neutral prebiotic oligosaccharide supplementation reduces the incidence of some allergic manifestations in the first 5 years of life. J Biol Regul Homeost Agents. 2012 Jul-Sep;26(3 Suppl):49–59.
  • Skórka A, Pieścik-Lech M, Kołodziej M, Szajewska H. Infant formulae supplemented with prebiotics: are they better than unsupplemented formulae? An updated systematic review. Br J Nutr. 2018 Apr;119(7):810–825.
  • Salvini F, Riva E, Salvatici E, Boehm G, Jelinek J, Banderali G, Giovannini M. A specific prebiotic mixture added to starting infant formula has long-lasting bifidogenic effects. J Nutr. 2011 Jul;141(7):1335–1339.